跳至主要内容
临床试验/NCT00733421
NCT00733421已完成4 期

The Effect of Anti-inflammatory Analgesics on Bone Repair, Pain and Gastro-intestinal Side Effects After Hallux Valgus Surgery; a Prospective Randomised Double-blind Placebo Controlled Study.

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Number of Patients Requiring Rescue Medication

研究概览

简要总结

The effects of none-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase inhibitors (Coxibs) on the formation of bone and fracture healing have been a matter of debate since long.

There is, however, limited data in humans and further prospective randomised studies are warranted. Ekman et al studied in a prospective randomised double blind study the effects of celecoxib, a selective cox-II-inhibitor, on pain and bone healing following spine surgery. They found significant effects on reduction of pain and need for opioid analgesics postoperatively but could see no negative effects the numbers of "none-unions" at a 1-year follow up 3.

In a similar prospective randomised double-blind study design significant effects in reduction of pain and need for rescue analgesia was seen from the use of celecoxib in the perioperative multi-modal pain strategy for cruciate-ligament reconstruction and no negative effects could bee seen on six month follow-up of the strength of the reconstructed ligament.

The aim of the present study is to further study the effects of the perioperative use of etoricoxib, a selective cox-II-inhibitor (Coxibs), in a prospective randomised double-blind study on bone healing, pain and need for rescue analgesia in patients undergoing elective Hallux Valgus surgery with a standardised surgical technique including an osteotomy of metatarsale I and excision of exostosis.

Study population 100 American Society of Anesthesiology (ASA) physiological status1-2 patients scheduled for elective hallux valgus (HV) surgery

The patients are going to be randomised into 2 groups, 50 patients in each;

  1. etoricoxib 90 mg once daily x 5
  2. tramadol 100 mg twice daily x 5

First line rescue medication t. paracetamol 1 gr up to 4 gram daily Second line rescue t. oxycodone 10 mg

Primary study variables:

  • X-ray evaluation (computer tomography (CT)-investigation) of bone healing assessed a CT-scan modelling of the osteotomy at twelve weeks after surgery
  • Number of patients requiring rescue medication
  • Patient assessment using "brief pain inventory" 24 hours and 2 weeks after surgery

Secondary study variables are;

  • Visual Analogue Scale (VAS) grading Day 1-7

  • Compliance to base medication

  • Need for rescue analgesia Day 1-7

  • Adverse Effects

  • Experience of any emetic symptoms

  • Experience of any gastrointestinal symptoms

  • Satisfaction with pain medication Day 20

  • Wound dressing Day 20

  • Clinical evaluation 17 weeks, final assessment

详细描述

See brief summary

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Health ASA 1-2 patients 18-65 years of age

排除标准

  • ASA/NSAID allergy
  • Renal disease
  • Lithium therapy
  • Complicated cardiovascular disease

研究组 & 干预措施

1

Experimental

Active study drug:

Etoricoxib 90 mg once daily

干预措施: etoricoxib (Drug)

2

Active Comparator

Tramadol 100 mg slow release twice daily

干预措施: tramadol (Drug)

结局指标

主要结局

Number of Patients Requiring Rescue Medication

时间窗: 7 day study period

Number of patients requiring any further pain medication

次要结局

  • Summary of Pain Scores, Day 1-7 of Visual Analogue Scale Grading of Pain(The first 7 days after surgery, during study pain medication)
  • Compliance to Base Medication(7-day study period, during study medication)
  • Gastro-intestinal Symptoms(during the 7- day pain medication period)
  • Dizziness/Sleepiness(During the 7-day pain medication period)
  • Wound Healing(16 week follow-up)
  • Satisfaction With Pain Medication(during the first 20 days after surgery, 1st outpatient clinic visit)
  • Patient Assessed Overall Satisfaction With Surgery/Outcome(16 weeks)
  • Patient Assessed Quality of Life(At 16-week post surgery follow-up)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验